Skip to main
We’re doing some system maintenance
  1. /
  2. Stocks
  3. /
  4. NeuroSense Therapeutics Ltd
NRSN

Buy NRSN Stock

NRSN
See NRSN stock price and Buy/Sell NeuroSense Therapeutics Ltd with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
NRSN

NeuroSense Therapeutics Ltd (NRSN)

About NeuroSense Therapeutics Ltd (NRSN)

Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company. The firm is focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. It is involved in the 2b/3 clinical trial using its product candidate, PrimeC in patients with ALS and also commencing research into other possible indications for the drug, including Alzheimer’s an...Read more
Market Cap
$18.68M
1 Year High
$8.18
Volume
31.54k
1 Year Low
$1.23
Price to Earnings Ratio
Open
$1.68
Dividend Rate
High
$1.79
Dividend Yield
Low
$1.60

Community

People who own or watch NRSN stock

NRSN Price Targets

What analysts think NRSN stock price will be.
$1.60
$7
337.5% Upside
$1$9

NRSN Stock Rating

What analysts recommend for NRSN stock, on a scale from 1(buy) to 5(sell).
Strong Buy1 / 5
BuyHoldSell

NRSN Stock Earnings

The value each NRSN share was expected to gain vs. the value that each NRSN share actually gained.
Expected
Actual

NRSN Stock News

Frequently Asked Questions (FAQ)

As of Sep 25, 2022, the market cap for NRSN stock is $18.68M

The 52-week high for NRSN stock is $8.18. The current NRSN stock price $1.6 is 80.44% below its 52-week high

The 52-week low for NRSN stock is $1.23. The current NRSN stock price $1.6 has increased 23.13% from its 52-week low

No, the NRSN stock does not pay dividends to its shareholders

The target price for NRSN stock is $7 based on the average of what a group of analyst think NRSN stock could be worth at a future date. This is not a prediction by Public.com

Buy NRSN Stock

NRSN
See NRSN stock price and Buy/Sell NeuroSense Therapeutics Ltd with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch NRSN stock
  • jlmillerjr78 avatar
  • CryptoKxng avatar
  • swayne56 avatar
  • tetragram avatar
  • DustInTheWindz avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Market data powered by Xignite.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.